The Ozempic phenomenon, initially hailed as a breakthrough in weight management by physicians and scientists, has morphed into an apocalyptic force, rippling far beyond the confines of diabetes control and weight loss, and into the very heart of America’s dining culture and food consumption. The medication’s appetite-diminishing effect is responsible for an unanticipated upheaval. It’s not just reshaping eating habits. It’s dismantling the entire business ecosystem. In the shadow of this catastrophe, major retailers like Walmart have sounded the alarm. Their once-bustling aisles, brimming with shoppers, now echo with an eerie stillness. “It’s like a ghost town over in the snack section,” said Walmart president Jeff Furner, his voice tinged…
